REGN Regeneron Pharmaceuticals, Inc. (2025-12-31) AI EQUITY RESEARCH July 02, 2026 Regeneron Pharmaceuticals, Inc. REGN Healthcare Rating Buy Price $624.72 Target $1223.57 Pitroski Score 4 Market Cap $83.60B P/E (Fwd) 18.6x P/B Ratio 2.67x ROE 14.9% Div. Yield 0.46% 52W Range $535.18 - $810.08